Not Tagged
takeda,nordic group,bms
['elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'lymsm', 'ptcl', 'lysa', 'lymphoma', 'nordic', 'celgene', 'takeda']
nordic nlg-t-01 1st line ptcl asct ph ii trial long term f/up #ash22
relander et al n=160 (exc alk+ alcl)
choep-14 asct
18-67yrs (med age 57yrs)
median fu 10.7 years outcome female prognosis if age &amp; ps = 2
fav outcome alcl patients w dusp22/irf4 (but only n=6) #lymsm 
#Lymphoma #CLL specialist @UCLH. Hon Associate Professor UCL. Chair UK T cell lymphoma working group. Past chair UK CNSL study group. views my own. #WiL #lymsm